Peter Goodwin, MD
Ophthalmology · Greenville, SCNPI 1649488594
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by US Retina LLC at 46.7% of the total. Reporting peaked in 2019 at $327 and has fallen 56.1% since, to $144 in 2025. That places this record below the midpoint for ophthalmology clinicians in SC, where the typical reported total is $1,895.
Across 17 payments — averaging $39.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$316
- AbbVie$109
- Mallinckrodt Hospital Products Inc.$87
- Alcon$51
- Astellas Pharma US Inc$49
- Bausch & Lomb, A Division Of Bausch Health US, LLC$26
- plus $38 from 2 others
What the payments were for
- Food & beverage$36053%
- Ownership interest$31647%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 1 | $316 |
| AbbVie(2 entities) | 5 | $109 |
| Mallinckrodt Hospital Products Inc. | 3 | $87 |
| Alcon | 2 | $51 |
| Astellas Pharma US Inc | 2 | $49 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $26 |
| Amgen | 1 | $22 |
| Bausch & Lomb Americas Inc. | 1 | $16 |
How this compares
$676 in reported general payments places this provider in the 25th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 106 | $3,596 |
| Timolol Maleate | 26 | $1,172 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 32 | $532 |
| Ofloxacin | 28 | $304 |
| Ketorolac Tromethamine | 23 | $194 |
| Latanoprost | 33 | $172 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Greenville
- Alan LeaheyGreenville$35K
- William BallingerGreenville$14K
- Dilip ThomasGreenville$8K
- Brian WelcomeGreenville$7K
- Kerry SolomonMt Pleasant$1.7M
- William ClarkWest Columbia$768K
- George WaringMt Pleasant$645K
- Karolinne RochaCharleston$552K
- Joseph BishopHilton Head Island$136K
- Erik HappMt Pleasant$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.